300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Kyrgyzstan
Zambia
Egypt
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Zimbabwe
Sweden
Taiwan
Norway
Oman
Tajikistan
Tunisia
Poland
Puerto Rico
Guernsey
Cameroon
Armenia
Andorra
Colombia
Sudan
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Qatar
Albania
Argentina
Bangladesh
Barbados
Belgium
Spain
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Angola
Europe
Cyprus
Mongolia
Peru
San Marino
Slovenia
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in France (September 2026)

The most active venture capital funds and angel investors investing in France Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
27 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $757k–$34M
Kurma Partners
VC Fund
9 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.7M–$98M
Idinvest Partners
VC Fund
7 France, United States, Germany Series B, Series A, Venture - Series Unknown Software, Health Care, Biotechnology $3.9M–$66M
Seventure Partners
VC Fund
7 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $3.3M–$63M
Omnes Capital
VC Fund
6 France, Germany, United States Series A, Series B Software, Biotechnology, Health Care $4.3M–$53M
Eurazeo
VC Fund
5 France, United States, Germany Series B, Seed Software, Information Technology, Health Care $3.2M–$125M
Sofinnova Partners
VC Fund
5 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Elaia
VC Fund
5 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Angels Santé
VC Fund
4 France, India, United States Seed, Venture - Series Unknown, Angel Health Care, Biotechnology, Medical Device $664k–$8.2M
AdBio partners
VC Fund
4 France, Spain, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $2.2M–$37M
Paca Investissement
VC Fund
4 France Seed, Venture - Series Unknown Software, Internet, Manufacturing $329k–$5.2M
Galia Gestion
VC Fund
3 France, United States Venture - Series Unknown, Series A Software, Manufacturing, Biotechnology $849k–$12M
Karista
VC Fund
3 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $768k–$33M
Boehringer Ingelheim Venture Fund
VC Fund
3 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
XAnge
VC Fund
3 France, Germany, Belgium Series A, Seed, Series B Software, SaaS, E-Commerce $1.1M–$75M
Blue Horizon Corporation
VC Fund
3 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $450k–$40M
Advent Life Sciences
VC Fund
3 United States, United Kingdom, France Series A, Series B, Series C Biotechnology, Health Care, Medical $5.5M–$97M
Beyond Impact
VC Fund
3 United States, France, United Kingdom Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $200k–$14M
Entrepreneurs First
VC Fund
3 United Kingdom, United States, India Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $55k–$30M
Social Starts
VC Fund
3 United States, Canada, Germany Seed, Series A, Pre-Seed Software, Health Care, Artificial Intelligence $100k–$14M
Siparex Groupe
VC Fund
2 France, United States, Italy Private Equity, Series A Manufacturing, Software, Information Technology $1.5M–$27M
Wendel Growth
VC Fund
2 France, Luxembourg Series A, Venture - Series Unknown Analytics, Open Source, Biotechnology $16M–$38M
Polytechnique Ventures
VC Fund
2 France, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Robotics, Information Technology $1.3M–$17M
Invus
VC Fund
2 United States, France, China Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $14M–$230M
Bernard Majoie
Angel
2 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care $1.4M–$2.7M
Andrew Nutter
Angel
2 France, United Kingdom, United States Seed, Pre-Seed, Venture - Series Unknown Software, SaaS, FinTech $550k–$4.9M
Bertrand Jacquelot
Angel
2 France, United States Pre-Seed, Seed, Angel Food and Beverage, E-Commerce, Information Technology $120k–$7.8M
Partech
VC Fund
2 United States, France, Germany Series A, Seed, Series B Software, E-Commerce, SaaS $1.1M–$56M
Eutopia VC
VC Fund
2 France, Belgium, Denmark Seed, Series A, Venture - Series Unknown E-Commerce, Retail, Food and Beverage $1.3M–$48M
Sofimac Investment Managers
VC Fund
2 France, Italy, Austria Seed, Series A Biotechnology, Health Care, Manufacturing $274k–$16M
Point Nine
VC Fund
2 Germany, United States, France Seed, Series A, Series B Software, SaaS, Internet $900k–$62M
Lundbeckfonden Ventures
VC Fund
2 United States, Denmark, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$95M
JDRF T1D Fund
VC Fund
2 United States, Canada, France Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $7M–$130M
Air Street Capital
VC Fund
2 United States, United Kingdom, France Seed, Series A, Series B Artificial Intelligence, Software, Biotechnology $1.8M–$300M
Sylvain Zimmer
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Angel Software, SaaS, Real Estate $200k–$10M
InnoBio Fund
VC Fund
2 France, United States Series A, Series B, Series C Biotechnology, Therapeutics, Pharmaceutical $14M–$26M
European Commission
VC Fund
2 France, Spain, Germany Grant, Seed, Pre-Seed Software, Biotechnology, Health Care $55k–$51M
Beurer
VC Fund
2 Germany, France, Estonia Seed, Series A, Pre-Seed Health Care, Medical, Software $1.2M–$10M
Mtec Holding Gmbh
VC Fund
2 France Seed, Series A Computer, Health Care, Life Science
WiSEED
VC Fund
2 France, Norway Seed, Venture - Series Unknown, Series A Software, Biotechnology, Manufacturing $384k–$7.8M
AQUITI Gestion
VC Fund
2 France, United States Venture - Series Unknown, Series A, Seed Software, Biotechnology, Manufacturing $170k–$18M
Kinled Holding
VC Fund
2 United Kingdom, United States, Switzerland Seed, Series A Biotechnology, Health Care, Software $594k–$40M
IRDI SORIDEC Gestion
VC Fund
2 France, Brazil, Singapore Seed, Series A, Venture - Series Unknown Software, Biotechnology, Medical $1.3M–$13M
Alexandria Venture Investments
VC Fund
2 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
Thia Ventures
VC Fund
2 United States, France, Denmark Series A, Seed, Pre-Seed Biotechnology, Health Care, Manufacturing $3.4M–$48M
Heartcore Capital
VC Fund
2 Denmark, United States, Germany Seed, Series A, Series B Software, Artificial Intelligence, FinTech $1.2M–$58M
Horizons Ventures
VC Fund
2 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Software, Artificial Intelligence $1M–$110M
Societe Generale Asset Management
VC Fund
1 France, United States, Germany Series B, Series A Biotechnology, Software, Health Care
Meusinvest (Noshaq)
VC Fund
1 Belgium, France, Germany Series A, Seed Biotechnology, Health Care, Medical
Banque Populaire Group
VC Fund
1 France Seed, Pre-Seed Manufacturing, Energy, Software
Access all 332 investors in France Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 27 investments in France Life Science startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1646
  • Round size: Seed $757k–$6.1M; Series A $2.8M–$34M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $27M in 2025

Portfolio highlights

  • Melvan — Melvan develops, finances, builds and operates solar and wind installations, combined, where relevant, with storage facilities.
  • AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
  • MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in France Life Science startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 145
  • Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fresh fund, raised $236M in 2024

Portfolio highlights

  • EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 7 investments in France Life Science startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series B, Series A, Venture - Series Unknown
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 329
  • Round size: Series A $3.9M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.7M–$65M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $97M in 2021

Portfolio highlights

  • Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
  • Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
  • StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 7 investments in France Life Science startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 258
  • Round size: Series A $3.3M–$28M; Series B $3.4M–$63M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 6 investments in France Life Science startups

Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 185
  • Round size: Series A $4.3M–$41M; Series B $4.4M–$53M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely actively investing — fresh fund, raised $132M in 2025

Portfolio highlights

  • SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
  • Adictiz — Adictiz, a French company founded in 2009 by Charles Christory, develops and publishes social games for the web and mobile phones.With successful brands including “Space Dog” and “What a Stupid Pigeon”, which attract close to 2.5 million players every month, Adictiz has established itself as an expert player in social and mobile gaming.Basedat the EuraTechnologies economic excellence hub in Lille, which is dedicated to serving information and communication technology companies, Adictiz set up Adictiz Studio in late 2011, which specialises in the creation of customised social games for brands. Adictiz Studio was recently selected by Facebook as a PMD (Preferred Marketing Developer).
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Show all investments...

Eurazeo
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series B, Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 375
  • Round size: Seed $3.2M–$16M; Series B $17M–$125M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.6B in 2026

Portfolio highlights

  • Excelya — Excelya is an R&D company that specializes in consulting, clinical trials, therapeutic research, data management, and medical writing.
  • Fonoa — Manage your sales tax, VAT, and GST obligations seamlessly through our API, globally. For internet businesses around the world, we make taxes simple, automated, borderless, and accessible via our API.
  • Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 348
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 237
  • Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fresh fund, raised $154M in 2026

Portfolio highlights

  • Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Zenchef — Zenchef was created in 2010 and has more than 7000 customers in 15 different countries. Zenchef has developed a complete customer experience management tool (before, during and after the service) without commission or intermediary for restaurateurs. The restaurant owner remains independent! With only one software, manage all your reservations, yourwebsite, your digital menus, the click & collect, your reviews, your customer file, the digital payment by QR Code, your marketing campaigns...
Show all investments...

Angels Santé
VC Fund · Puteaux, Ile-de-France, France · 4 investments in France Life Science startups

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Venture - Series Unknown, Angel
  • Geography: France, India, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1.1M–$4.6M; Angel $687k–$1.3M; Venture - Series Unknown $664k–$8.2M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
  • StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 32
  • Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $116M in 2021

Portfolio highlights

  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Paca Investissement
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Show more...

Investment focus

  • Industry: Software, Internet, Manufacturing
  • Stage:Seed, Venture - Series Unknown
  • Geography: France

Investor stats

  • Total investments: 73
  • Round size: Seed $329k–$1.7M; Venture - Series Unknown $1.1M–$5.2M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France · 3 investments in France Life Science startups

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Venture - Series Unknown, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 55
  • Round size: Series A $849k–$7.2M; Venture - Series Unknown $1M–$12M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $26M in 2013

Portfolio highlights

  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 3 investments in France Life Science startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 158
  • Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $2.5M–$33M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — raised $44M in 2021

Portfolio highlights

  • AlephD — The programmatic performance company
  • Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
  • Voluntis — Voluntis design digital therapeutics to people across multiple areas to self-manage their treatment improving real-world outcomes.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in France Life Science startups, 6 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 107
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France · 3 investments in France Life Science startups

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Show more...

Investment focus

  • Industry: Software, SaaS, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: France, Germany, Belgium

Investor stats

  • Total investments: 236
  • Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6.6M–$75M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $261M in 2021

Portfolio highlights

  • ELDIM — Eldim proposes photometric and calorimetric products of instrumentation allowing to qualify the ergonomic parameters and the quality of the image of the flat screens. Its customers (manufacturers of components or sreen-Sharp, Sony, Samsung, -or integrators-IBM, Apple, Valeo, Honeywell, Nokia, Motorola-) are mainly foreigns.
  • Skello — Skello is the The AI HR solution for frontline teams. HR tools were designed for offices, yet 55% of the workforce works on their feet and deserves technology designed for the field. Our mission is to improve their daily lives. For managers and HR directors, Skello offers seamless management from hiring to the payslip: our AI automatestime-consuming tasks so they can anticipate and supervise while maintaining full control. For teams, Skello guarantees a transparent and collaborative experience from their very first day. In July 2026, we reached a major milestone with the announcement of €200 million in funding to accelerate our development. After 10 years spent listening to our customers, this new chapter solidifies our conviction: technology must assist and facilitate work, without ever replacing humans. Our ambition is to be the go-to AI HR management solution for all frontline teams in Europe.
  • Aerospacelab — Aerospacelab makes access to space simple. By combining our satellite platforms with mission payloads, Aerospacelab is able to deliver end-to-end satellite solutions tailored to meet your business needs.
Show all investments...

Blue Horizon Corporation
VC Fund · Zürich, Zurich, Switzerland · 3 investments in France Life Science startups

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 109
  • Round size: Seed $2M–$10M; Pre-Seed $450k–$6.3M; Series A $2M–$40M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $222M in 2021

Portfolio highlights

  • WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
  • EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
  • foodforecast — AI supported solution to reduce food waste.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 3 investments in France Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 73
  • Round size: Series A $5.5M–$51M; Series B $21M–$97M; Series C $30M–$80M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Beyond Impact
VC Fund · Montreux, Vaud, Switzerland · 3 investments in France Life Science startups

Beyond Impact Advisors is created to facilitate investment in products and services that are either inherently vegan in nature or are cruelty-free and remove mankind’s reliance on the raising of animals for slaughter.Beyond Impact’s core investment thesis centers on sustainability as a pillar of risk management and economic valuation. Due to theheavy environmental impact, the use of animals is inherently unsustainable and alternatives need to be found and funded. Coinciding with this we are seeing an accelerating societal shift in favour of vegan, cruelty-free and plant-based alternatives, based on the environmental imperative, health concerns and compassion for animals.As such, Beyond Impact targets significantly impactful companies which have positioned their products and services to meet this growing demand, favouring those with clear technological advantages and whose products outstrip the qualities of the animal-derived material they replace.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Seed $670k–$7M; Pre-Seed $200k–$3.4M; Series A $2.9M–$14M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Jay&Joy — Jay&Joy is the first plant-based creamery in France engaged in manufacturing alternatives to cheese made from almond milk and cashew nuts.
  • Yeastup — Yeastup transforms brewer's yeast into proteins & fibers for food & supplements. Contact us for sustainable ingredient solutions.
  • Perfat Technologies — Perfect fats for better foods.
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 3 investments in France Life Science startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 447
  • Round size: Seed $567k–$6.7M; Pre-Seed $55k–$2.9M; Series A $5.1M–$30M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely actively investing — fresh fund, raised $133M in 2026

Portfolio highlights

  • Sourcepulse — Your early warning system for software delivery (YC S23)
  • EverSettled — Navigate the probate process with confidence. We provide a free checklist, guidance, and support to help families find clarity in the chaos of loss.
  • Peripheral Labs — Peripheral Labs provides technology for live media and spatial intelligence.
Show all investments...

Social Starts
VC Fund · San Francisco, California, United States · 3 investments in France Life Science startups

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, Germany

Investor stats

  • Total investments: 384
  • Round size: Seed $187k–$3.8M; Pre-Seed $100k–$2.3M; Series A $3.3M–$14M
  • Lead/follow: 2% lead, 98% follow
  • Last fund: Likely still investing — raised $8.9M in 2022

Portfolio highlights

  • Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
  • Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
  • Bark Technologies — Bark's parental controls help you monitor social media, manage screen time, and track location to keep your family safer online.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Siparex Groupe
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Private Equity, Series A
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 129
  • Round size: Series A $1.5M–$11M; Private Equity $1.7M–$27M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: Likely still investing — raised $452M in 2022

Portfolio highlights

  • Cofarco — Official COFARCO twitter account. Commodity finance and trade credit insurance specialist.
  • DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
  • Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
Show all investments...

Wendel Growth
VC Fund · 2 investments in France Life Science startups

Wendel Growth is an investment arm of Wendel.

Show more...

Investment focus

  • Industry: Analytics, Open Source, Biotechnology
  • Stage:Series A, Venture - Series Unknown
  • Geography: France, Luxembourg

Investor stats

  • Total investments: 6
  • Round size: Series A $33M–$38M; Venture - Series Unknown $16M–$16M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
  • TaDaweb — Tadaweb is the first small data platform to scale Open Source intelligence for discovering and analysing information on the Internet.
Show all investments...

Polytechnique Ventures
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Polytechnique Ventures support entrepreneurs from the School's ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, United Kingdom, Germany

Investor stats

  • Total investments: 26
  • Round size: Seed $2M–$11M; Pre-Seed $1.3M–$2.7M; Series A $6.5M–$17M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $39M in 2023

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • Goodvest — Goodvest is an investment app (life insurance) that builds a better world, in line with your values and promoting performance.
  • Jimmy — Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission. The company designs compact generators that use high-temperature reactor technology to create heat without combustion and deliver it to industrial systems through heat transfer circuits. Its systems connect to factoryinfrastructure and provide heat for processes such as steam production, thermal oil heating, or hot air generation. Jimmy installs, operates, and manages these generators as integrated energy units adapted to the heat demand of each industrial site. The technology relies on micro-reactor architecture and modular deployment so multiple units can be combined to match required thermal output. Through this approach, Jimmy provides industrial heat that replaces fossil-fuel-based heat sources in manufacturing and processing operations.
Show all investments...

Invus
VC Fund · New York, New York, United States · 2 investments in France Life Science startups

Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: United States, France, China

Investor stats

  • Total investments: 294
  • Round size: Series A $14M–$200M; Series B $35M–$230M; Series C $31M–$165M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2021

Portfolio highlights

  • Marlette Funding — Marlette Funding is a financial services technology company that is simplifying how consumers borrow money. Its team of consumer finance leaders developed and power the Best Egg personal loan product which can be used to consolidate debt and to finance purchases or services like home improvement or medical expenses. Through its streamlined onlineloan platform, qualified applicants can instantly review loan offers, select a loan and receive funds in as little as one day.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • Lexicon Pharmaceuticals — Lexicon Pharmaceuticals, Inc. (formerly Lexicon Genetic) a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The company's drug candidates include LX1031, which has completed Phase II clinical trialsfor the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolution's Chemetics platform chemistry technology.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in France Life Science startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 6
  • Round size: Seed $1.4M–$2.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $550k–$4.9M; Pre-Seed $902k–$3.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
Show all investments...

Bertrand Jacquelot
Angel · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.

Show more...

Investment focus

  • Industry: Food and Beverage, E-Commerce, Information Technology
  • Stage:Pre-Seed, Seed, Angel
  • Geography: France, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Show all investments...

Partech
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Show more...

Investment focus

  • Industry: Software, E-Commerce, SaaS
  • Stage:Series A, Seed, Series B
  • Geography: United States, France, Germany

Investor stats

  • Total investments: 654
  • Round size: Seed $1.1M–$9M; Series A $4.2M–$28M; Series B $9M–$56M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $345M in 2026

Portfolio highlights

  • Mercanis — Source services smarter and drive automation along your source-to-settle process. Discover how Mercanis enables you to collaborate with best-in-class suppliers across your departments.
  • Revibe — Buy refurbished & used electronics (Smartphones, Laptops) in UAE at Revibe. Free delivery & 12 months warranty. Certified tech by our experts. Order Now!
  • Jungo Software — Experience the future of driving with in-cabin sensing technology. Learn how this accident prevention system saves lives
Show all investments...

Eutopia VC
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

Show more...

Investment focus

  • Industry: E-Commerce, Retail, Food and Beverage
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Belgium, Denmark

Investor stats

  • Total investments: 16
  • Round size: Seed $2.4M–$10M; Series A $4M–$48M; Venture - Series Unknown $1.3M–$9.4M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $45M in 2019

Portfolio highlights

  • Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
  • Moderato — Moderato is a retail and wholesale company that manufactures and supplies a range of beverages online to various sectors.
  • SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Show all investments...

Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France · 2 investments in France Life Science startups

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Italy, Austria

Investor stats

  • Total investments: 74
  • Round size: Seed $274k–$3.1M; Series A $1.6M–$16M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Point Nine
VC Fund · Berlin, Berlin, Germany · 2 investments in France Life Science startups

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Internet
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United States, France

Investor stats

  • Total investments: 284
  • Round size: Seed $900k–$7.7M; Series A $3.2M–$24M; Series B $9M–$62M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $173M in 2022

Portfolio highlights

  • Sereact — The only real-world verified Vision-Language-Action AI. Proven at scale. Trained on the world's largest dataset of robotic picks.
  • Delivery Hero — Delivery Hero is the world's leading local delivery company. We are on a mission to deliver an amazing experience - fast, easy, and to your door.
  • Polar Analytics — Your Shopify Analytics. Effortless. Centralized. Smart. Connect your datasource in one clic, automatically calculate KPIs. Visualize them all in one place. Get alerts and recommendations in realtime
Show all investments...

Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in France Life Science startups

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $10M–$53M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
  • Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Show all investments...

JDRF T1D Fund
VC Fund · Boston, Massachusetts, United States · 2 investments in France Life Science startups

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 56
  • Round size: Series A $7M–$105M; Series B $18M–$130M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
  • Tetragenetics — Our protein production platform provides recombinant transmembane proteins, including ion channels and GPCRs, for antibody drug discovery
  • vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom · 2 investments in France Life Science startups

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 48
  • Round size: Seed $1.8M–$14M; Series A $14M–$48M; Series B $64M–$300M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $232M in 2026

Portfolio highlights

  • STARK — EUROPEAN DEFENCE SOVEREIGNTY
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Macrodata Labs — Reviewing and annotating robotics data by hand does not scale. Macrodata Labs automates QA, subtask annotation, 3D hand tracking, and reward scoring across large robot and egocentric datasets. Send a few sample episodes for a free demo.
Show all investments...

Sylvain Zimmer
Angel · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.

Show more...

Investment focus

  • Industry: Software, SaaS, Real Estate
  • Stage:Seed, Pre-Seed, Angel
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $740k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

InnoBio Fund
VC Fund · Maisons-alfort, Ile-de-France, France · 2 investments in France Life Science startups

InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in thehealthcare market.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States

Investor stats

  • Total investments: 13
  • Round size: Series A $16M–$21M; Series B $14M–$21M; Series C $18M–$26M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Millendo Therapeutics — Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
  • Diotheris — Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria. The company's products are based on live bacteria includes NASOFLORE which targets Staphylococcus aureus, enabling the prevention of infections due to major pathogen and protecting patients against biologicalthreats.
  • AlgoTherapeutix — AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Show all investments...

European Commission
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in France Life Science startups, 43 in the past 12 months

The official website of the European Commission, providing access to information about its political priorities, policies and services

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Grant, Seed, Pre-Seed
  • Geography: France, Spain, Germany

Investor stats

  • Total investments: 302
  • Round size: Seed $117k–$10M; Grant $117k–$51M; Pre-Seed $55k–$5.4M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • EU-CONEXUS — European University for Smart Urban Coastal Sustainability
  • Leonardo — Leader in Aerospace, Defence & Security
  • Egyptian Electricity Transmission Company — Egyptian Electricity Transmission Company manages, operates, and maintains high-voltage electricity grids. It acts purely as a utility infrastructure operator to transmit bulk power from power plants to regional distribution networks.
Show all investments...

Beurer
VC Fund · Ulm, Baden-Wurttemberg, Germany · 2 investments in France Life Science startups

We offer a range of more than 500 products, and ever since 1919 we have been delivering what our claim promises: health and wellness. Our product ranges will ensure you feel great all-round! From medical products specialized in prevention and diagnosis, to weight and diagnosis products, as well as therapy devices an

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, France, Estonia

Investor stats

  • Total investments: 6
  • Round size: Seed $1.2M–$2.5M; Series A $6.8M–$10M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • PKVitality — PKvitality is an advanced bio-wearable company. Fusing 20 years of expertise in consumer electronics with 20 years of biological research, PKvitality brings its patented SKinTaste technology to market. SKinTaste is a revolutionary biosensor array that uses micro-needles (<1mm long) to collect and analyze chemical compositions of the interstitialfluid found just below the surface of the skin. Using this technology, PKvitality is developing K'Watch, a continuous glucose monitor in the form of a smartwatch to change the lives of millions of diabetics.
  • Healthy Networks — Healthy Networks flagship product, LungPass, is a smart stethoscope for lungs. It distinguishes serious and mild respiratory conditions by analysing lung sounds & symptoms. Easy to use, precise and affordable, LungPass is poised to become a go-to solution for people to own their respiratory health and for healthcare providers to expand theirservice coverage.
  • microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.
Show all investments...

Mtec Holding Gmbh
VC Fund · 2 investments in France Life Science startups

Holding Company

Show more...

Investment focus

  • Industry: Computer, Health Care, Life Science
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PKVitality — PKvitality is an advanced bio-wearable company. Fusing 20 years of expertise in consumer electronics with 20 years of biological research, PKvitality brings its patented SKinTaste technology to market. SKinTaste is a revolutionary biosensor array that uses micro-needles (<1mm long) to collect and analyze chemical compositions of the interstitialfluid found just below the surface of the skin. Using this technology, PKvitality is developing K'Watch, a continuous glucose monitor in the form of a smartwatch to change the lives of millions of diabetics.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in France Life Science startups

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: France, Norway

Investor stats

  • Total investments: 34
  • Round size: Seed $384k–$3.3M; Series A $1.3M–$7.8M; Venture - Series Unknown $1M–$6.5M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France · 2 investments in France Life Science startups

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 59
  • Round size: Seed $170k–$4.1M; Series A $849k–$18M; Venture - Series Unknown $1.2M–$12M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $7.9M in 2010

Portfolio highlights

  • Synboli — Synboli is a deep-tech company that combines artificial intelligence and proprietary chemistry technologies to accelerate the discovery and development of novel polymers and advanced materials. Its AI-powered platform predicts polymer properties, designs new molecular structures, and integrates laboratory testing to reduce material developmenttimelines.
  • Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
  • CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 2 investments in France Life Science startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 142
  • Round size: Seed $594k–$14M; Series A $1.7M–$40M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Show all investments...

IRDI SORIDEC Gestion
VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in France Life Science startups

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Brazil, Singapore

Investor stats

  • Total investments: 54
  • Round size: Seed $1.7M–$5.8M; Series A $3.7M–$13M; Venture - Series Unknown $1.3M–$12M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
  • Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
  • ThIA Santé Mentale —
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 2 investments in France Life Science startups, 19 in the past 12 months

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 297
  • Round size: Seed $2M–$30M; Series A $12M–$100M; Series B $25M–$150M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
  • Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 2 investments in France Life Science startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 22
  • Round size: Seed $3.4M–$20M; Series A $6.8M–$48M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
  • uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Show all investments...

Heartcore Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in France Life Science startups

Heartcore Capital invests in companies re-enchanting the world through technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Denmark, United States, Germany

Investor stats

  • Total investments: 212
  • Round size: Seed $1.2M–$12M; Series A $3.3M–$27M; Series B $9.6M–$58M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fresh fund, raised $179M in 2024

Portfolio highlights

  • Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
  • PhaseTree — Materials design simulation company - PhaseTree ApS
  • Everywear Games — Everywear Games is the world’s leading wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s gamesare consistently on top of global charts.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in France Life Science startups

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 321
  • Round size: Seed $1M–$10M; Series A $6.2M–$47M; Series B $11M–$110M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • HZO — HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments. It provides water protection solutions for electronics manufacturers by introducing a durable film to components during assembly. The company specializes in the fields of nanotechnology, waterproofing, electronics,nano-coating, full-submersion.It was founded in 2011 and headquartered in Morrisville, North Carolina.
  • Cortica — Cortica is an Israeli company founded in 2007 with leading AI technology for visual perception. Its unique self-learning technology, backed by more than 200 patents, allows Cortica to develop multiple products that can read and understand images on a human level­–thereby significantly exceeding the capabilities of the major tech companies.Cortica is the first AI company capable of human-level image understanding. Even the most advanced technology has never been able to understand the visual world as well as people do - until now. By leveraging proprietary brain research to create unsupervised AI, Cortica has developed the most effective computer vision system. This technology, based upon the mammal cortex is utilized to build products impacting many industries. The company’s mission is to lead the emerging AI market with a strong focus on computer vision and establish its "universal visual index of the world" as the global standard­­–enabling machines to read and understand images. Cortica's vision is to embed its capabilities in all next-generation platforms where understanding images is a critical task. This includes autonomous vehicles, smart city applications, security cameras, drones, media, robotics, and medical image analysis. Cortica's headquarters and R&D center are based in Israel employing over 80 leading AI researchers and veterans of elite Israeli military intelligence units.
  • Corephotonics — Corephotonics is the pioneer and worldwide market leader of dual camera technologies for smartphones and mobile devices, providing a perfect mobile camera photography experience, novel photography features and superior image quality
Show all investments...

Societe Generale Asset Management
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 47
  • Lead/follow: no public data

Portfolio highlights

  • Augure — Improve your brand performance with Launchmetrics' leading software solutions for fashion, lifestyle and beauty brands
  • Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
  • METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 1 investments in France Life Science startups, 8 in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 75
  • Lead/follow: no public data

Portfolio highlights

  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
Show all investments...

Banque Populaire Group
VC Fund · Casablanca, Grand Casablanca, Morocco · 1 investments in France Life Science startups

Banque Populaire Group provides banking and credit services for individuals, international and corporate.

Show more...

Investment focus

  • Industry: Manufacturing, Energy, Software
  • Stage:Seed, Pre-Seed
  • Geography: France

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • ATAWEY — Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than asimple response: a solution that adapts to your uses.The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.
  • Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
  • Meccellis Biotech — Meccellis Biotech is a company specializing in acellular dermal matrices and tissue engineering, developing medical devices in La Rochelle.
Show all investments...

Life Science Investor funding in France at a glance

Stats across 240 deals from 332 investors.

332
investors
in France Life Science startups
240
deals
in France Life Science startups
$4.4M
median round
in France Life Science startups
35%
lead investors
lead at least one round
20%
Seed
most common funding stage
95/5
VC / Angel
share of investor count

Access all 332 investors in France Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 332 investors investing in France Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists